Metastatic small cell neuroendocrine carcinoma of the cervix treated with the PD-1 inhibitor, nivolumab: a case report
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2053-6844
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Metastatic small cell neuroendocrine carcinoma of the cervix treated with the PD-1 inhibitor, nivolumab: a case report ; volume:4 ; number:1 ; day:2 ; month:2 ; year:2017 ; pages:1-5 ; date:12.2017
Gynecologic oncology research and practice ; 4, Heft 1 (2.2.2017), 1-5, 12.2017
- Keyword
-
Krebs
Onkologie
- Creator
-
Paraghamian, Sarah E.
- Contributor
-
Longoria, Teresa C.
Eskander, Ramez N.
SpringerLink (Online service)
- DOI
-
10.1186/s40661-017-0038-9
- URN
-
urn:nbn:de:1111-2017022611719
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Paraghamian, Sarah E.
- Longoria, Teresa C.
- Eskander, Ramez N.
- SpringerLink (Online service)
Other Objects (12)
Nivolumab in combination with radiotherapy for metastatic esophageal neuroendocrine carcinoma after esophagectomy: a case report
Radioembolization for Metastatic Neuroendocrine Tumors
Nivolumab for Metastatic Cutaneous Squamous Cell Carcinoma
Metastatic Merkel cell carcinoma response to nivolumab
Neuroendocrine carcinoma of the cervix: a systematic review of the literature
Vogt-Koyanagi-Harada Disease-Like Uveitis during Nivolumab (Anti-PD-1 Antibody) Treatment for Metastatic Cutaneous Malignant Melanoma
Enhanced IL-34 expression in Nivolumab-resistant metastatic melanoma
Erratum to: Metastatic Merkel cell carcinoma response to nivolumab
The prognostic impact of the immune microenvironment in small-cell neuroendocrine carcinoma of the uterine cervix: PD-L1 and immune cell subtypes
Response to anti-PD1 therapy with nivolumab in metastatic sarcomas
Immune-Related Meningoencephalitis following Nivolumab in Metastatic Renal Cell Carcinoma
Nivolumab Induced Lethal Aplastic Anemia in a Patient with Metastatic Melanoma
Nivolumab in combination with radiotherapy for metastatic esophageal neuroendocrine carcinoma after esophagectomy: a case report
Radioembolization for Metastatic Neuroendocrine Tumors
Nivolumab for Metastatic Cutaneous Squamous Cell Carcinoma
Metastatic Merkel cell carcinoma response to nivolumab
Neuroendocrine carcinoma of the cervix: a systematic review of the literature
Vogt-Koyanagi-Harada Disease-Like Uveitis during Nivolumab (Anti-PD-1 Antibody) Treatment for Metastatic Cutaneous Malignant Melanoma
Enhanced IL-34 expression in Nivolumab-resistant metastatic melanoma
Erratum to: Metastatic Merkel cell carcinoma response to nivolumab
The prognostic impact of the immune microenvironment in small-cell neuroendocrine carcinoma of the uterine cervix: PD-L1 and immune cell subtypes
Response to anti-PD1 therapy with nivolumab in metastatic sarcomas
Immune-Related Meningoencephalitis following Nivolumab in Metastatic Renal Cell Carcinoma
Nivolumab Induced Lethal Aplastic Anemia in a Patient with Metastatic Melanoma
Nivolumab in combination with radiotherapy for metastatic esophageal neuroendocrine carcinoma after esophagectomy: a case report
Radioembolization for Metastatic Neuroendocrine Tumors
Nivolumab for Metastatic Cutaneous Squamous Cell Carcinoma
Metastatic Merkel cell carcinoma response to nivolumab
Neuroendocrine carcinoma of the cervix: a systematic review of the literature
Vogt-Koyanagi-Harada Disease-Like Uveitis during Nivolumab (Anti-PD-1 Antibody) Treatment for Metastatic Cutaneous Malignant Melanoma
Enhanced IL-34 expression in Nivolumab-resistant metastatic melanoma
Erratum to: Metastatic Merkel cell carcinoma response to nivolumab
The prognostic impact of the immune microenvironment in small-cell neuroendocrine carcinoma of the uterine cervix: PD-L1 and immune cell subtypes
Response to anti-PD1 therapy with nivolumab in metastatic sarcomas
Immune-Related Meningoencephalitis following Nivolumab in Metastatic Renal Cell Carcinoma